ERBB2 and neoplasm: Examination of relapsed tumors indicated that most of the tumor cells have lost HER2 expression (Fig. 6D and Fig. S10B), suggesting a competitive release of HER2-independent subpopulations or an acquired loss of HER2 dependence.